Carl Zeiss Meditec
€31.30Change from previous close: +0.32%Absolute change: +€0.10
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €2.71B
- Enterprise value
- €3.26B
- P/E (trailing 12 months)
- 22.6
- Forward P/E
- 21.0
- PEG
- 1.08
- Price/book
- 1.29
- Price/sales
- 1.24
- EV/EBITDA
- 15.0
- EV/revenue
- 1.49
Profitability and growth
- Gross margin
- 51.6%
- Operating margin
- 11.1%
- Net margin
- 5.6%
- Revenue growth (year over year)
- 2.4%
- Earnings growth (year over year)
- 97.5%
Financial health
- Total cash
- €23.9M
- Total debt
- €580.95M
- Debt/equity
- 0.28
Dividends
- Annual dividend per share
- €0.55
- Dividend yield
- 1.8%
- Payout ratio
- 43.8%
- Ex-dividend date
- March 27, 2026
Analysts and estimates
- Average price target
- €27.15
- Median price target
- €27.00
- High price target
- €35.00
- Low price target
- €18.10
- Analysts with a price target
- 15
- Forward EPS
- €1.48
- EPS estimate, current year
- €1.33
Shares and trading
- Beta
- 1.36
- Average volume
- 253.59K
- Shares outstanding
- 87.54M
- Float
- 34.19M
- Institutional ownership
- 19.2%
- Insider ownership
- 59.1%